LKB1 inactivation modulates chromatin accessibility to drive metastatic progression

Sarah E. Pierce(Broad Institute), Monte M. Winslow(Stanford University), Michael C. Bassik(Stanford Health Care), Jeffrey M. Granja(Enable Biosciences (United States)), Howard Y. Chang(Stanford University), Rui Tang(Jinan University), David M. Feldser(Cancer Research Institute), Jennifer J. Brady(Stanford University), William J. Greenleaf(Stanford University), Aubrey B. Pierce(Stanford University), M. Ryan Corces(Gladstone Institutes), Pauline Chu(Stanford University), Min K. Tsai(Stanford University)
bioRxiv (Cold Spring Harbor Laboratory)
March 30, 2021
Cited by 4


Related Papers